Philip Morris Products S.A.
52
2
4
42
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.5%
6 terminated/withdrawn out of 52 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
79%
33 of 42 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
Role: lead
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
Role: lead
Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention
Role: lead
Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes
Role: lead
Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants
Role: lead
Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking.
Role: lead
Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers
Role: lead
Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)
Role: lead
Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification Study
Role: lead
Effect of Tobacco Heating System (THS) on Closed Lower Limb Fracture Healing
Role: collaborator
Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG
Role: lead
Effect of Switching From Cigarette Smoking to THS on Systemic Endothelial Function in Subjects With Established Atherosclerotic Disease
Role: lead
Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers
Role: lead
Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.
Role: lead
Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS
Role: lead
Japanese Post-Market Cohort Study
Role: lead
Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)
Role: lead
Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
Role: lead
Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence
Role: lead
Cross-Sectional Survey on the Use of Tobacco Products - London (UK)
Role: lead